#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Intermediary stadium of Hodgkin’s lymphoma – citius, altius, or fortius? – editorial


Authors: D. Feltl 1;  J. Marková 2
Authors‘ workplace: Radioterapeutická klinika Fakultní nemocnice s poliklinikou, Ostrava, přednosta prim. MUDr. David Feltl, Ph. D. 1;  Oddělení klinické hematologie FN Královské Vinohrady, Praha, přednosta doc. MUDr. Tomáš Kozák, Ph. D. 2
Published in: Vnitř Lék 2007; 53(1): 7-8
Category: Editorials


Sources

1. Ng AK, Bernardo MV, Weller E et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 2002; 20: 2101-2108.

*2. Carde P, Cavalli R, Diehl V et al. Treatment of advanced Hodgkin’s disease: is there a standard therapy? The Hematology Journal 2000; 1: 282-290.*

3. Horning SJ, Hoppe RT, Breslin J et al. Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial. J Clin Oncol 2002; 3: 630-637.

4. Yahalom J. Don't throw out the baby with the bathwater: on optimizing cure and reducing toxicity in Hodgkin's lymphoma. J Clin Oncol 2006; 24: 544-548.

Labels
Diabetology Endocrinology Internal medicine

Article was published in

Internal Medicine

Issue 1

2007 Issue 1

Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#